Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases

V Ivasiv, C Albertini, AE Gonçalves… - Current Topics in …, 2019 - ingentaconnect.com
Molecular hybridization is a well-exploited medicinal chemistry strategy that aims to combine
two molecules (or parts of them) in a new, single chemical entity. Recently, it has been …

Quinoline: a promising antitubercular target

RS Keri, SA Patil - Biomedicine & Pharmacotherapy, 2014 - Elsevier
Tuberculosis (TB) remains a global public health problem in recent years. TB originated
mainly from various strains of Mycobacterium tuberculosis, is a highly infectious and chronic …

[HTML][HTML] Recent advances in leishmaniasis treatment

TS Tiuman, AO Santos, T Ueda-Nakamura… - International Journal of …, 2011 - Elsevier
About 1.5 million new cases of cutaneous leishmaniasis and 500 000 new cases of visceral
leishmaniasis occur each year around the world. For over half a century, the clinical forms of …

Anti-Giardia Drug Discovery: Current Status and Gut Feelings

A Riches, CJS Hart, KR Trenholme… - Journal of medicinal …, 2020 - ACS Publications
Giardia parasites are ubiquitous protozoans of global importance that impact a wide range
of animals including humans. They are the most common enteric pathogen of cats and dogs …

Giardiasis: characteristics, pathogenesis and new insights about treatment

V Vivancos, I González-Alvarez… - Current topics in …, 2018 - ingentaconnect.com
Giardia intestinalis infection causes enterocytes damage and loss of brush border of the
epithelial cells of the intestine that leads to shortening of microvilli and altered epithelial …

Hybrid compounds as direct multitarget ligands: a review

M Oliveira Pedrosa, RM Duarte da Cruz… - Current topics in …, 2017 - ingentaconnect.com
Molecular Hybridization is an approach in rational drug design where new chemical entities
are obtained by combining two or more pharmacophoric units from different bioactive …

Antituberculosis drug research: a critical overview

Beena, DS Rawat - Medicinal research reviews, 2013 - Wiley Online Library
The increasing drug resistance of M ycobacterium tuberculosis to the currently used drugs
and HIV coinfection has caused alarm in the international scientific community …

The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines

L CS Pinheiro, L M. Feitosa, M O. Gandi, F F. Silveira… - Molecules, 2019 - mdpi.com
Based on medicinal chemistry tools, new compounds for malaria treatment were designed.
The scaffolds of the drugs used to treat malaria, such as chloroquine, primaquine …

Drug discovery for cutaneous leishmaniasis: a review of developments in the past 15 years

HN Corman, CW McNamara, MA Bakowski - Microorganisms, 2023 - mdpi.com
Leishmaniasis is a group of vector-borne, parasitic diseases caused by over 20 species of
the protozoan Leishmania spp. The three major disease classifications, cutaneous, visceral …

Quinoline: an attractive scaffold in drug design

LFE Moor, TRA Vasconcelos… - Mini Reviews in …, 2021 - benthamdirect.com
Quinoline and its derivatives comprise an important group of heterocyclic compounds that
exhibits a wide range of pharmacological properties such as antibacterial, antiviral …